Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 458

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial

Open access
Szefler, Stanley J, Mitchell, Herman, Sorkness, Christine A, Gergen, Peter J, O'Connor, George T, Morgan, Wayne J, Kattan, Meyer, Pongracic, Jacqueline A, Teach, Stephen J, Bloomberg, Gordon R, Eggleston, Peyton A, Gruchalla, Rebecca S, Kercsmar, Carolyn M, Liu, Andrew H, Wildfire, Jeremy J, Curry, Matthew D, Busse, William W·2008·The Lancet

Abstract

Background Preliminary evidence is equivocal regarding the role of exhaled nitric oxide in clinical asthma management. This study evaluates the usefulness of eNO as an adjunct to asthma guidelines-based clinical care among inner-city adolescents and young adults. Methods A randomized, double-blind, parallel-group trial was conducted with 546 inner-city participants, aged 12–20 years, with persistent asthma (Clinicaltrials.gov Identifier: NCT00114413). A run-in characterization period of 3 weeks on an initial controller regimen preceded a 46-week double-blind treatment strategy. Participants were randomized to either, treatment based on NAEPP guidelines alone (Reference Group) or the guidelines plus FENO measurements (FENO Group). Primary outcome was asthma symptom days and secondary outcome was acute asthma exacerbations. Findings During the 46-week treatment period, the number of asthma symptom days, pulmonary function, unscheduled care visits, and hospitalizations did not differ between the treatment groups (mean asthma symptom days were 1.93 [95% CI 1.74-2.11] in the FENO group vs. 1.89 [1.71-1.74] in the control group; difference 0.04 [-0.29-0.22], p=0.7796). The FENO Group received a significantly higher inhaled corticosteroid dose (118.9 mcg/day difference, 95% CI: 48.5-189.3, P=0.0010) as compared to the Reference Group. Asthma symptoms remained low in both groups following randomization with 57% (306/534) of the participants well controlled for at least 80% of visits.. Interpretation A coordinated asthma management program facilitated achieving good control in the majority of participants. The addition of FENO as a control indicator resulted in a higher dose of inhaled corticosteroids without a clinically important improvement in symptomatic asthma control.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(08)61448-8

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 458

Metadata

Authors
Szefler, S. J., Mitchell, H., Sorkness, C. A., Gergen, P. J., O'Connor, G. T., Morgan, W. J., Kattan, M., Pongracic, J. A., Teach, S. J., Bloomberg, G. R., Eggleston, P. A., Gruchalla, R. S., Kercsmar, C. M., Liu, A. H., Wildfire, J. J., Curry, M. D., & Busse, W. W.
Venue
The Lancet
Publisher
Elsevier BV
Published
2008-09
Volume
372
Issue
9643
Pages
1065-1072
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2149411747
Cited by
458
References
7
FWCI
33.98
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(08)61448-8
The paper
Szefler, S. J., Mitchell, H., Sorkness, C. A., Gergen, P. J., O'Connor, G. T., Morgan, W. J., Kattan, M., Pongracic, J. A., Teach, S. J., Bloomberg, G. R., Eggleston, P. A., Gruchalla, R. S., Kercsmar, C. M., Liu, A. H., Wildfire, J. J., Curry, M. D., & Busse, W. W. (2008). Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(08)61448-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.